Conference Coverage

VIDEO: Larger lentigo maligna lesions increase risk


 

AT NOAH 57

References

ASHEVILLE, N.C. – What are the risk factors for invasive melanoma in patients with lentigo maligna? Size, for one thing, according to Dr. Suzanne M. Olbricht.

In an interview at the annual meeting of the Noah Worcester Dermatological Society, Dr. Olbricht of the Lahey Hospital and Medical Center in Burlington, Mass., reviewed evidence suggesting that the recurrence rate is highest for large lesions. “This is important information that helps us think about the treatments we can use,” she said.

Dr. Olbricht had no financial conflicts to disclose.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

Laser-enhanced 5-FU scores with squamous cell, basal cell patients
MDedge Dermatology
VIDEO: PDT tops blue-light therapy for actinic keratosis
MDedge Dermatology
VIDEO: Nanodermatology Society roundtable tackles tough questions on photoprotection
MDedge Dermatology
Dermoscopical screening surpasses app for melanoma diagnosis
MDedge Dermatology
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Dermatology
Melanoma incidence drops for U.S. children and teens
MDedge Dermatology
Short but simple theme guides AK treatment recommendations
MDedge Dermatology
Teens who tan indoors do it often
MDedge Dermatology
Fractional laser resurfacing plus ALA-PDT upped AK clearance
MDedge Dermatology
Imaging guides BCC laser ablation
MDedge Dermatology